Cited by 863Clinical practice guidelines implementationHealth Promotion and Cardiovascular PreventionCardiovascular Health and Risk Factors

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, Guy De Backer (Belgium), Helmut Gohlke (Germany), Ian Graham (Ireland), Željko Reiner (Croatia), WM Monique Verschuren (The Netherlands), Christian Albus (Germany), Pascale Benlian (France), Gudrun Boysen (Denmark), Renata Cifkova (Czech Republic), Christi Deaton (UK), Shah Ebrahim (UK), Miles Fisher (UK), Giuseppe Germano (Italy), Richard Hobbs (UK), Arno Hoes (The Netherlands), Sehnaz Karadeniz (Turkey), Alessandro Mezzani (Italy), Eva Presco·2012·European Journal of Preventive Cardiology

Abstract

Other experts who contributed to parts of the guidelines: Marie Therese Cooney (Ireland). ESC Committee for Practice Guidelines (CPG): Jeroen Bax (Chairman) (The Netherlands), Helmut Baumgartner (Germany), Claudio Ceconi (Italy), Veronica Dean (France), Christi Deaton (UK), Robert Fagard (Belgium), Christian Funck-Brentano (France), David Hasdai (Israel), Arno Hoes (The Netherlands), Paulus Kirchhof (Germany), Juhani Knuuti (Finland), Philippe Kolh (Belgium), Theresa McDonagh (UK), Cyril Moulin (France), Bogdan A. Popescu (Romania), Željko Reiner (Croatia), Udo Sechtem (Germany), Per Anton Sirnes (Norway), Michal Tendera (Poland), Adam Torbicki (Poland), Alec Vahanian (France), Stephan Windecker (Switzerland) Document Reviewers: Christian Funck-Brentano (CPG Review Coordinator) (France), Per Anton Sirnes (CPG Review Coordinator) (Norway), Victor Aboyans (France), Eduardo Alegria Ezquerra (Spain), Colin Baigent (UK), Carlos Brotons (Spain), Gunilla Burell (Sweden), Antonio Ceriello (Spain), Johan De Sutter (Belgium), Jaap Deckers (The Netherlands), Stefano Del Prato (Italy), Hans-Christoph Diener (Germany), Donna Fitzsimons (UK), Zlatko Fras (Slovenia), Rainer Hambrecht (Germany), Piotr Jankowski (Poland), Ulrich Keil (Germany), Mike Kirby (UK), Mogens Lytken Larsen (Denmark), Giuseppe Mancia (Italy), Athanasios J. Manolis (Greece), John McMurray (UK), Andrzej Pająk (Poland), Alexander Parkhomenko (Ukraine), Loukianos Rallidis (Greece), Fausto Rigo (Italy), Evangelista Rocha (…

Integrity signals

Registry

Crossref · 10.1177/2047487312450228

Cites

178 of 178 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In primary prevention among individuals with no previous cardiovascular events, the net benefit of aspirin is more controversial.

    “In primary prevention, however, among individuals with no previous cardiovascular events, its net benefit is more controversial (156,168).”
  • Aspirin has been shown to be effective in reducing cardiovascular morbidity and mortality in high-risk individuals with previous MI or stroke (secondary prevention).

    “Aspirin has been shown to be effective in reducing cardiovascular morbidity and mortality in high-risk individuals with previous MI or stroke (secondary prevention) and is strongly recommended.”
  • For people with documented ASCVD, use of aspirin for secondary prevention has far greater benefit than risk.

    “For people with documented ASCVD, use of aspirin for secondary prevention has far greater benefit than risk; for this indication, aspirin is still recommended (168).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, G. D. B. (.
Venue
European Journal of Preventive Cardiology
Published
2012-07-04
Volume
19
Issue
4
Pages
585-667
ISSN
  • 2047-4873 (ISSN-L)
  • 2047-4881
OpenAlex
W1510658613
Cited by
863
References
178
Citations by year
2026: 3 · 2025: 10 · 2024: 16 · 2023: 24 · 2022: 23 · 2021: 26 · 2020: 29 · 2019: 64 · 2018: 45 · 2017: 68 · 2016: 93 · 2015: 114 · 2014: 111 · 2013: 81 · 2012: 58
FWCI
112.40
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Preventive Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
  • Open Repository and Bibliography (University of Liège) (submittedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
  • Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Keywords
cardiovascular disease prevention, primary prevention, secondary prevention, cardiovascular risk factors, cardiovascular risk assessment, lifestyle modification, cardiovascular risk management
MeSH terms
Cardiology, Cardiovascular Diseases, Europe, Humans, Preventive Health Services, Risk Factors, Comorbidity, Risk Assessment, Patient Selection, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review